活检证实的急性侵袭性真菌性鼻窦炎多中心结局回顾
多因素分析显示免疫刺激治疗与1个月死亡率降低70%相关(p=0.02),血液恶性肿瘤、近期化疗、非典型真菌及海绵窦受累与生存更差相关。
要点
- 免疫刺激治疗与1个月死亡率降低70%相关(p=0.02)。
- 血液恶性肿瘤、近期化疗、非典型真菌及海绵窦受累提示预后更差。
- 血液恶性肿瘤患者中三分之一诊断时中性粒细胞绝对计数>1000,ANC与预后无关。
核心结论
- 免疫刺激治疗可能改善急性侵袭性真菌性鼻窦炎的短期生存,但需前瞻性研究验证。
- 非典型真菌感染患者死亡风险可能更高。
研究设计与样本
- 采用单因素和多因素Cox回归分析诊断后1个月和3个月的生存相关因素。
主要发现
- 单因素分析中,血液恶性肿瘤3个月HR 3.7(p=0.01)、近期化疗3个月HR 2.3(p=0.02)、近期骨髓移植3个月HR 2.5(p=0.02)、非典型真菌感染1个月HR 3.1(p=0.04)与更差生存相关。
- 单因素分析中,A1c%升高1个月HR 0.7(p=0.01)和手术清创1个月HR 0.1(p=0.001)与改善生存相关。
- 多因素分析中,血液恶性肿瘤、近期化疗、非典型病原体和海绵窦受累与更差生存相关。
- 多因素分析中,免疫刺激治疗与1个月死亡率降低70%相关(p=0.02)。
- 血液恶性肿瘤患者中三分之一诊断时ANC>1000,ANC在这些患者中与预后无关。
临床怎么用
- 对急性侵袭性真菌性鼻窦炎患者,应评估血液恶性肿瘤、近期化疗、非典型真菌及海绵窦受累等预后不良因素。
- 免疫刺激治疗可能作为改善短期生存的辅助策略,但需结合前瞻性研究证据。
- 手术清创与改善生存相关,可作为综合治疗的一部分。
局限性
- 回顾性研究设计。
- 免疫刺激治疗的生存获益需前瞻性研究证实。
- ANC在诊断和预后中的重要性需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute invasive fungal sinusitis (AIFS) is a rare, aggressive infection occurring in immunocompromised patients. In this study we examined factors that affect survival in AIFS, and whether immune-stimulating therapies (IST) improve survival. METHODS: Pathology records of biopsy-proven AIFS were reviewed from 3 academic institutions from 1995 to 2016. Univariate and multivariate Cox regressions were performed at 1 and 3 months from diagnosis. RESULTS: One hundred fourteen patients were included; 45 received IST. In the univariate analysis, the following factors were associated with worse survival: hematologic malignancy (3-month hazard ratio [HR], 3.7; p = 0.01); recent chemotherapy (within 1 month of AIFS diagnosis) (3-month HR, 2.3; p = 0.02); recent bone marrow transplant (BMT) (3-month HR, 2.5; p = 0.02); and infection with atypical fungi (1-month HR, 3.1; p = 0.04). The following were associated with improved survival in univariate analysis: increasing A1c% (1-month HR, 0.7; p = 0.01) and surgical debridement (1-month HR, 0.1; p = 0.001). One third of patients with a hematologic malignancy had an absolute neutrophil count (ANC) >1000 at the time of diagnosis. ANC was not associated with prognosis in these patients. The following were associated with worse survival in multivariate analyses: hematologic malignancy; recent chemotherapy; atypical organisms; and cavernous sinus extension. In multivariate analyses, IST was associated with a 70% reduction in mortality at 1 month (p = 0.02). CONCLUSION: We presented the largest series of AIFS. Further studies are needed to examine the importance of ANC in diagnosis and prognosis. Patients diagnosed with atypical organisms may be at higher risk of death. IST likely improves short-term survival, but prospective studies are needed.
引用
- Wandell GM, Miller C, Rathor A, et al. A multi-institutional review of outcomes in biopsy-proven acute invasive fungal sinusitis. Int Forum Allergy Rhinol. 2018. PMID: 29979836. doi:10.1002/alr.22172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。